I’m worth… survey

  Thank you for taking the time to answer questions about your work in relation to hepatitis C. Your answers will be anonymised and will...

Finding the right voice

CGL has been consulting with young people on the best ways for its youth services to get their message across. DDN reports on the...

Meet the fentanyls

With a vast range of forms and potencies, the fentanyl family bring too many unknowns. Kevin Flemen gives an essential guide. Another day, another drug...

Vital connections

Most drug-related deaths are of people not in treatment. DDN visits Equinox outreach team in Brighton to hear how they engage with a growing...

Market forces

Drug-related deaths: A strong message from Addaction’s Mortality Matters conference was that treatment services need to put competition to one side and challenge the conditions...

Knowledge exchange

Drug-related deaths: NHS Trusts from across England came together to mark a vital new initiative in tackling drug-related deaths, as Danny Hames reports. For a number...

Slow on the draw

Why are smokers reluctant to exchange the risks of cigarettes for the health benefits of e-cigs, asks Neil McKeganey. E-cigarettes have been characterised by Public...

On a mission to cure hep C

Curing hepatitis C has become a reality and makes sense for the public purse as well as public health. So let’s get on with...

Stay ahead of CQC

Pleased with your CQC inspection or bruised by the experience? David Finney gives you the key issues. The first phase of inspections of substance misuse...

Vote of confidence

As Phoenix Futures launches its new strategy, with the strapline ‘The charity that is confident about recovery’, DDN hears about the ideas behind it...